XORTX Therapeutics Inc (XRX)

CSE
3.5400
-0.1800(-4.84%)
  • Volume:
    163,392
  • Bid/Ask:
    3.5000/3.5600
  • Day's Range:
    3.4900 - 3.8800
  • Type:Equity
  • Market:Canada
  • ISIN:CA98420Q2071
  • CUSIP:98420Q207

XRX Overview

Prev. Close
3.72
Day's Range
3.49-3.88
Revenue
-
Open
3.7
52 wk Range
1.1153-9.979
EPS
-0.41
Volume
163,392
Market Cap
44.73M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
111,518
P/E Ratio
-
Beta
0.12
1-Year Change
151.28%
Shares Outstanding
12,634,687
Next Earnings Date
-
What is your sentiment on XORTX Therapeutics Inc?
or
Market is currently closed. Voting is open during market hours.

XORTX Therapeutics Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellStrong SellSellBuy
Technical IndicatorsStrong SellStrong SellStrong BuyStrong SellNeutral
SummaryStrong SellStrong SellStrong SellStrong SellNeutral

XORTX Therapeutics Inc Company Profile

XORTX Therapeutics Inc Company Profile

Employees
0
Market
Canada

XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, hypertension, insulin resistance, and diabetic nephropathy. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. XORTX Therapeutics Inc. is headquartered in Vancouver, Canada.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.